Type 2 diabetes may raise risk of severe dengue, warns review

A new review paper suggests that individuals with Type 2 diabetes are at a significantly higher risk of developing severe complications from dengue fever. Experts recommend integrating dengue vaccination into routine diabetes care to mitigate these risks.
Why it matters
With over 100 million diabetics in India, this finding highlights a critical intersection between chronic disease management and infectious disease prevention.
People with Type 2 diabetes face a higher risk of severe, life-threatening dengue complications, according to a review paper slated for publication in the International Journal of Diabetes & Technology, which calls for integrating dengue vaccination into routine diabetes care to protect vulnerable populations in dengue-endemic regions better. The study authors note that persistently high blood sugar impairs immune function and damages blood vessels, which makes people with diabetes more susceptible to severe dengue infection. According to the authors, such patients are more likely to develop an exaggerated inflammatory response, or a “cytokine storm”, which can result in dengue haemorrhagic fever, internal bleeding and, in severe cases, dengue shock syndrome, a potentially fatal condition marked by a sharp fall in blood pressure. DISCLAIMER: This article is based on information from the public domain and/or the experts we spoke to. Always consult your health practitioner before starting any routine.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in